Cancellation of state registration. Kapastat

September 22, 2016
Active substances:
Trade names:
ICD-10:
I.A15-A19    Tuberculosis
Cancellation of registration, capreomycin, Kapastat, tuberculosis, treatment of tuberculosis

The Ministry of Health of the Russian Federation in accordance with Article 32 of Federal Law No. 61-FZ of 12.04.2010 "On the circulation of medicinal products" decided to abolish state registration and exclude from the state register of medicinal products for medical use of the medicinal product (registration certificate P N013861 / 01 from 01.04.2008 issued by EliLilly East SA, Switzerland):

Kapastat (trade name of the medicinal product)

Capreomycin (international non-proprietary, or grouping, or chemical name medicinal product)

lyophilizate for the preparation of solution for intravenous and intramuscular administration, 1 g dosage form, dosage)

Lilly Pharma Fertigung und Distribution GmbH & Co. KG, Germany Teichweg 3, 35396 Giessen, Germany

ZAO "BIOKOM", Russia, 355016, Stavropol, Chapayevsky proezd, 54 Eli Lilly and Company, USA, Indianapolis, Indiana 46285, USA (name and address of the location of the manufacturer of the medicinal product)

on the basis of filing by the authorized legal entity of the MP of JSC "Eli Lilly Vostok SA", Russia a registration application for the medicinal product.